KELLY STERK: Open Payments
NPI 1740770791 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 18 payments from 7 companies in 2025. Trend: 2023 $431 · 2024 $346 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $171 |
| Lilly USA, LLC | 1 | $122 |
| Kowa Pharmaceuticals America, Inc. | 1 | $121 |
| Janssen Biotech, Inc. | 2 | $48 |
| Insulet Corporation | 1 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $17 |
Products named: GEMTESA, KISUNLA, ZORYVE, ERLEADA, OMNIPOD, PLUVICTO, PYLARIFY.
Industry payments across IA — which companies pay providers there.
